Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- APOG -10.9% (also, CFO resigns), MSM -1.1%
Other news:
- DRUG -6.7% ($100 mln stock offering)
- COMP -6.4% (to offer $750.0 million in aggregate principal amount of convertible senior notes due 2031)
- STNE -6% (new CEO)
- ARWR -2.7% (plans $500 million convertible notes offering alongside $200 million common stock sale)
- BBOT -1.9% (New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Ka Pipeline Programs)
- TXG -1.6% (CareDx and 10x Genomics (TXG) to launch ImmuneScape program -- A multiomics research platform to decode transplant rejection and drug response)
- ACET -1.6% (Provides Corporate Update and Highlights Expected 2026 Milestones)
- PRAX -1.4% (prices offering of 2,212,000 shares of its common stock at $260.00 per share)
- SKT -0.9% ($200 mln exchangeable notes offering)
- WBD -0.8% (Warner Bros. Discovery Board of directors unanimously recommends shareholders reject amended Paramount (PSKY) tender offer)